Stay updated on Pembrolizumab vs Placebo in NSCLC Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab vs Placebo in NSCLC Clinical Trial page.

Latest updates to the Pembrolizumab vs Placebo in NSCLC Clinical Trial page
- ChecktodayChange DetectedThe study record history shows a new revision tag, v3.7.0, replacing the previous v3.6.6, indicating an updated revision entry for the record rather than a substantive change to study content.SummaryDifference0.1%

- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedA new revision entry, v3.6.6, was added to the study history, replacing the previous v3.6.5. This indicates an updated version of the study record.SummaryDifference0.1%

- Check35 days agoChange DetectedThe record history now lists Revision: v3.6.5 as the latest version, replacing the previous v3.6.4. This reflects a new update published to the study record.SummaryDifference0.1%

- Check50 days agoChange DetectedA new site revision v3.6.4 was added to the history, replacing the previous v3.6.3. This reflects a software release note in the record history and does not affect study data.SummaryDifference0.1%

- Check78 days agoChange DetectedA new release entry for Revision: v3.6.3 was added to the history and the entry for Revision: v3.6.0 was removed. This represents an update to the site's revision log rather than changes to core study data.SummaryDifference0.1%

- Check93 days agoChange DetectedThe history now shows that recruitment is closed ('No longer looking for participants'), and the changes include adding the revision tag v3.6.0 while removing the previous tag v3.5.5.SummaryDifference0.2%

Stay in the know with updates to Pembrolizumab vs Placebo in NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab vs Placebo in NSCLC Clinical Trial page.